Each year, 1.5 million Americans are affected by eye injury or disease which damages the cornea. Mohan has identified minimally invasive ways to deliver treatments both topically and by injection. He has also invented a new method of using nanoparticles to introduce therapeutic genes to treat diseased corneas in animals. He hopes to translate the gene therapy to human medicine.